FK-317

Details

Stereochemistry	UNKNOWN
Molecular Formula	C19H21N3O8
Molecular Weight	419.3853
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@]12CN3OC(OC(C)=O)([C@@H](COC(N)=O)C4=C(OC)C=C(C=O)C=C34)[C@@]1([H])N2C(C)=O

InChI

InChIKey=BUZDGGFWWPZBIN-DHZLCAPXSA-N

InChI=1S/C19H21N3O8/c1-9(24)22-14-6-21-13-4-11(7-23)5-15(27-3)16(13)12(8-28-18(20)26)19(30-21,17(14)22)29-10(2)25/h4-5,7,12,14,17H,6,8H2,1-3H3,(H2,20,26)/t12-,14-,17-,19?,22?/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H21N3O8
Molecular Weight	419.3853
Charge	0
Count

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	3 / 4
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.	1998	9619755

Patents

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:22:33 UTC 2023` Edited by `admin` on `Fri Dec 15 16:22:33 UTC 2023`
Record UNII	85J6JHT779
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FK-317

Common Name

English

FR-073317

Code

English

Code System Code Type Description

EPA CompTox

DTXSID10858817

Created by admin on Fri Dec 15 16:22:33 UTC 2023 , Edited by admin on Fri Dec 15 16:22:33 UTC 2023

PRIMARY

PUBCHEM

121492536

Created by admin on Fri Dec 15 16:22:33 UTC 2023 , Edited by admin on Fri Dec 15 16:22:33 UTC 2023

PRIMARY

CAS

102409-92-7

Created by admin on Fri Dec 15 16:22:33 UTC 2023 , Edited by admin on Fri Dec 15 16:22:33 UTC 2023

NON-SPECIFIC STEREOCHEMISTRY

FDA UNII

85J6JHT779

Created by admin on Fri Dec 15 16:22:33 UTC 2023 , Edited by admin on Fri Dec 15 16:22:33 UTC 2023

PRIMARY

Related Record Type Details


					85J6JHT779

FK-317

ACTIVE MOIETY